tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 341 are a BUY (94.2%), 21 are a HOLD (5.8%).
Analyst Steven Seedhouse, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 36.26% that have a potential upside of 48.57% achieved within 263 days.
Steven Seedhouse’s has documented 652 price targets and ratings displayed on 50 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on BLTE, Belite Bio ADR at 14-Aug-2026.
Analyst best performing recommendations are on ABCL (ABCELLERA BIOLOGICS).
The best stock recommendation documented was for ABCL (ABCELLERA BIOLOGICS) at 8/6/2026. The price target of $12 was fulfilled within 13 days with a profit of $5.47 (83.77%) receiving and performance score of 64.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 4 months 28 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 5 months ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 5 months 7 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 7 months 29 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 7 months 29 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
Which stock is Steven Seedhouse most bullish on?
Which stock is Steven Seedhouse most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
